메뉴 건너뛰기




Volumn 70, Issue 2, 2010, Pages 171-179

Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis

Author keywords

gastro oesophageal reflux disease; lansoprazole; mosapride; reflux oesophagitis; therapeutic effectiveness

Indexed keywords

LANSOPRAZOLE; MOPRIDE; MOSAPRIDE CITRATE; PLACEBO; UNCLASSIFIED DRUG;

EID: 77954527373     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03696.x     Document Type: Article
Times cited : (28)

References (33)
  • 1
    • 17644416461 scopus 로고    scopus 로고
    • Epidemiology of gastro-esophageal reflux disease: A systematic review
    • Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-esophageal reflux disease: a systematic review. Gut 2005 54 : 710 717.
    • (2005) Gut , vol.54 , pp. 710-717
    • Dent, J.1    El-Serag, H.B.2    Wallander, M.A.3    Johansson, S.4
  • 3
    • 33645800356 scopus 로고    scopus 로고
    • Systematic review on epidemiology of gastro-esophageal reflux disease in Asia
    • Wong BC, Kinoshita Y. Systematic review on epidemiology of gastro-esophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006 4 : 398 407.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 398-407
    • Wong, B.C.1    Kinoshita, Y.2
  • 4
    • 0032033112 scopus 로고    scopus 로고
    • The impact of gastro-esophageal reflux disease on health-related quality of life
    • Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastro-esophageal reflux disease on health-related quality of life. Am J Med 1998 104 : 252 258.
    • (1998) Am J Med , vol.104 , pp. 252-258
    • Revicki, D.A.1    Wood, M.2    Maton, P.N.3    Sorensen, S.4
  • 5
    • 0033580405 scopus 로고    scopus 로고
    • Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma
    • Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 831.
    • (1999) N Engl J Med , vol.340 , pp. 825-831
    • Lagergren, J.1    Bergstrom, R.2    Lindgren, A.3    Nyren, O.4
  • 6
    • 0036679396 scopus 로고    scopus 로고
    • Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma
    • Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 2002 97 : 1930 1936.
    • (2002) Am J Gastroenterol , vol.97 , pp. 1930-1936
    • Avidan, B.1    Sonnenberg, A.2    Schnell, T.G.3    Chejfec, G.4    Metz, A.5    Sontag, S.J.6
  • 7
    • 0030962574 scopus 로고    scopus 로고
    • Speed of healing and symptom relief in grade II to IV gastro-esophageal reflux disease: A meta-analysis
    • Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastro-esophageal reflux disease: a meta-analysis. Gastroenterology 1997 112 : 1798 1810.
    • (1997) Gastroenterology , vol.112 , pp. 1798-1810
    • Chiba, N.1    De Gara, C.J.2    Wilkinson, J.M.3    Hunt, R.H.4
  • 9
    • 13744261420 scopus 로고    scopus 로고
    • Updated guidelines for the diagnosis and treatment of gastro-esophageal reflux disease
    • DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastro-esophageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
    • (2005) Am J Gastroenterol , vol.100 , pp. 190-200
    • Devault, K.R.1    Castell, D.O.2
  • 13
    • 0141621818 scopus 로고    scopus 로고
    • Step-down from multiple- to single-dose proton pump inhibitors (PPIs): A prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs
    • Inadomi JM, McIntyre L, Bernard L, Fendrick AM. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003 98 : 1940 1944.
    • (2003) Am J Gastroenterol , vol.98 , pp. 1940-1944
    • Inadomi, J.M.1    McIntyre, L.2    Bernard, L.3    Fendrick, A.M.4
  • 15
    • 22844451154 scopus 로고    scopus 로고
    • Systematic review: Proton-pump inhibitor failure in gastro-esophageal reflux disease - Where next?
    • Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-esophageal reflux disease - where next? Aliment Pharmacol Ther 2005 22 : 79 94.
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 79-94
    • Fass, R.1    Shapiro, M.2    Dekel, R.3    Sewell, J.4
  • 16
    • 0031963781 scopus 로고    scopus 로고
    • The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-esophageal reflux disease
    • Ruth M, Hamelin B, Rohss K, Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-esophageal reflux disease. Aliment Pharmacol Ther 1998 12 : 35 40.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 35-40
    • Ruth, M.1    Hamelin, B.2    Rohss, K.3    Lundell, L.4
  • 17
    • 0142012129 scopus 로고    scopus 로고
    • The effect of mosapride on esophageal motor function and acid reflux in patients with gastro-esophageal reflux disease
    • Ruth M, Finizia C, Cange L, Lundell L. The effect of mosapride on esophageal motor function and acid reflux in patients with gastro-esophageal reflux disease. Eur J Gastroenterol Hepatol 2003 15 : 1115 1121.
    • (2003) Eur J Gastroenterol Hepatol , vol.15 , pp. 1115-1121
    • Ruth, M.1    Finizia, C.2    Cange, L.3    Lundell, L.4
  • 20
    • 12344321002 scopus 로고    scopus 로고
    • Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastro-esophageal reflux disease: A randomized trial
    • Madan K, Ahuja V, Kashyap PC, Sharma MP. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastro-esophageal reflux disease: a randomized trial. Dis Esophagus 2004 17 : 274 278.
    • (2004) Dis Esophagus , vol.17 , pp. 274-278
    • Madan, K.1    Ahuja, V.2    Kashyap, P.C.3    Sharma, M.P.4
  • 21
    • 42049120978 scopus 로고    scopus 로고
    • Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of pro-kinetics to proton pump inhibitor therapy
    • Miyamoto M, Haruma K, Takeuchi K, Kuwabara M. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of pro-kinetics to proton pump inhibitor therapy. J Gastroenterol Hepatol 2008 23 : 746 751.
    • (2008) J Gastroenterol Hepatol , vol.23 , pp. 746-751
    • Miyamoto, M.1    Haruma, K.2    Takeuchi, K.3    Kuwabara, M.4
  • 24
    • 48449089904 scopus 로고    scopus 로고
    • Evaluation of upper abdominal symptoms using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease in patients with laryngo-pharyngeal reflux symptoms
    • Oridate N, Takeda H, Mesuda Y, Nishizawa N, Furuta Y, Asaka M, Fukuda S. Evaluation of upper abdominal symptoms using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease in patients with laryngo-pharyngeal reflux symptoms. J Gastroenterol 2008 43 : 519 523.
    • (2008) J Gastroenterol , vol.43 , pp. 519-523
    • Oridate, N.1    Takeda, H.2    Mesuda, Y.3    Nishizawa, N.4    Furuta, Y.5    Asaka, M.6    Fukuda, S.7
  • 26
    • 0024387213 scopus 로고
    • Efficacy of cisapride on symptoms and healing of gastro-esophageal reflux disease: A review
    • discussion 27-8
    • Richter JE. Efficacy of cisapride on symptoms and healing of gastro-esophageal reflux disease: a review. Scand J Gastroenterol Suppl 1989 165 : 19 27, discussion 27-8.
    • (1989) Scand J Gastroenterol Suppl , vol.165 , pp. 19-27
    • Richter, J.E.1
  • 27
    • 0023904170 scopus 로고
    • Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients
    • Ceccatelli P, Janssens J, Vantrappen G, Cucchiara S. Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients. Gut 1988 29 : 631 635.
    • (1988) Gut , vol.29 , pp. 631-635
    • Ceccatelli, P.1    Janssens, J.2    Vantrappen, G.3    Cucchiara, S.4
  • 28
    • 10744232346 scopus 로고    scopus 로고
    • Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h esophageal and intra-gastric pH in Chinese subjects with gastro-esophageal reflux disease
    • Wong WM, Lai KC, Hui WM, Lam KF, Huang JQ, Hu WH, Wong NY, Lam CL, Xia HH, Chan AO, Lam SK, Wong BC. Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h esophageal and intra-gastric pH in Chinese subjects with gastro-esophageal reflux disease. Aliment Pharmacol Ther 2004 19 : 455 462.
    • (2004) Aliment Pharmacol Ther , vol.19 , pp. 455-462
    • Wong, W.M.1    Lai, K.C.2    Hui, W.M.3    Lam, K.F.4    Huang, J.Q.5    Hu, W.H.6    Wong, N.Y.7    Lam, C.L.8    Xia, H.H.9    Chan, A.O.10    Lam, S.K.11    Wong, B.C.12
  • 29
    • 0036088963 scopus 로고    scopus 로고
    • A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: A Dutch multicentre trial
    • Mulder CJ, Westerveld BD, Smit JM, Oudkerk Pool M, Otten MH, Tan TG, van Milligen de Wit AW, de Groot GH. A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. Eur J Gastroenterol Hepatol 2002 14 : 649 656.
    • (2002) Eur J Gastroenterol Hepatol , vol.14 , pp. 649-656
    • Mulder, C.J.1    Westerveld, B.D.2    Smit, J.M.3    Oudkerk Pool, M.4    Otten, M.H.5    Tan, T.G.6    Van Milligendewit, A.W.7    De Groot, G.H.8
  • 30
    • 0026080619 scopus 로고
    • Motivation and expectancy factors in symptom perception: A laboratory study of the placebo effect
    • Jensen MP, Karoly P. Motivation and expectancy factors in symptom perception: a laboratory study of the placebo effect. Psychosom Med 1991 53 : 144 152.
    • (1991) Psychosom Med , vol.53 , pp. 144-152
    • Jensen, M.P.1    Karoly, P.2
  • 31
    • 33645510406 scopus 로고    scopus 로고
    • Review article: The role of acid suppression in patients with non-erosive reflux disease or functional heartburn
    • Suppl.
    • DeVault KR. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn. Aliment Pharmacol Ther 2006 23 (Suppl. 1 33 9.
    • (2006) Aliment Pharmacol Ther , vol.23 , Issue.1 , pp. 33-9
    • Devault, K.R.1
  • 32
    • 3142668886 scopus 로고    scopus 로고
    • Patho-physiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn
    • Frazzoni M, De Micheli E, Zentilin P, Savarino V. Patho-physiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment Pharmacol Ther 2004 20 : 81 8.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 81-8
    • Frazzoni, M.1    De Micheli, E.2    Zentilin, P.3    Savarino, V.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.